Search

everythinglearnresearchcommunity

for

Search:↓

Ciclosporin might be a good alternative treatment for certain hearing loss that responds to steroids.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Lupus can be a rare cause of high calcium levels in the blood.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.